Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.390
-0.130 (-2.88%)
At close: Apr 28, 2026, 4:00 PM EDT
4.620
+0.230 (5.24%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $441.43 million as of April 28, 2026. Its market cap has increased by 805.15% in one year.
Market Cap
441.43M
Enterprise Value
352.98M
1-Year Change
805.15%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $441.43M, a decrease of -45.28%. That is a compound annual growth rate of -10.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 479.88M |
| Candel Therapeutics | 476.11M |
| Armata Pharmaceuticals | 473.30M |
| Larimar Therapeutics | 471.63M |
| Valneva SE | 470.89M |
| Aura Biosciences | 466.73M |
| Contineum Therapeutics | 463.34M |
| Ginkgo Bioworks Holdings | 458.09M |